Current real-life obsession as a good millennial: running.
Working on antimicrobial R&D education @gardp.bsky.social --> check out revive.gardp.org
.~* Views expressed are my own *~.
The trial has started enrolling newborn babies with sepsis at Kilifi County Hospital (Kilifi) Coast General Teaching & Referral Hospital (Mombasa) and Mbagathi Hospital (Nairobi).
The trial has started enrolling newborn babies with sepsis at Kilifi County Hospital (Kilifi) Coast General Teaching & Referral Hospital (Mombasa) and Mbagathi Hospital (Nairobi).
🔗 Read the TIME feature: time.com/collections/...
#TIME100
🔗 Read the TIME feature: time.com/collections/...
#TIME100
“From erections to resurrection — not womb to tomb.”
With that striking opening, Dr Teodora Elvira C. Wi reframes the conversation on STIs, maternal infections and neonatal sepsis, and why early action matters.
🎦Watch the rest of the session LIVE: bit.ly/3LVHIkF
#ACC2026
“From erections to resurrection — not womb to tomb.”
With that striking opening, Dr Teodora Elvira C. Wi reframes the conversation on STIs, maternal infections and neonatal sepsis, and why early action matters.
🎦Watch the rest of the session LIVE: bit.ly/3LVHIkF
#ACC2026
From womb to world, this session tackles one of the most urgent gaps in AMR: how we design, test and deliver antimicrobials for pregnant women, newborns and children.
🔗Tune in live now: portalapp.bsac.eventsair.com/VirtualAtten...
#ACC2026
Dr Wanatpreeya Phongsamart emphasized that equity in TB care means prioritizing pregnant women and children, who face high mortality yet remain underrepresented in research and trials🤱👶
💭🔗 Join us: bit.ly/3NTXxZG
#ACC2026
Dr Wanatpreeya Phongsamart emphasized that equity in TB care means prioritizing pregnant women and children, who face high mortality yet remain underrepresented in research and trials🤱👶
💭🔗 Join us: bit.ly/3NTXxZG
#ACC2026
The focus turns to preclinical antimicrobial development, with talks exploring lysin biotherapeutics, anti-virulence approaches and new adjunct therapies to tackle drug-resistant infections.
🎥 Join us now: portalapp.bsac.eventsair.com/VirtualAtten...
The focus turns to preclinical antimicrobial development, with talks exploring lysin biotherapeutics, anti-virulence approaches and new adjunct therapies to tackle drug-resistant infections.
🎥 Join us now: portalapp.bsac.eventsair.com/VirtualAtten...
Topic: Optimising multinational clinical trials with antimicrobials and the critical role of clinical trial networks 🧬🌍
Featuring Prof David Paterson, National University of Singapore and ADVANCE-ID.
🔗 bit.ly/4rmSteA
@advance-id.bsky.social
Topic: Optimising multinational clinical trials with antimicrobials and the critical role of clinical trial networks 🧬🌍
Featuring Prof David Paterson, National University of Singapore and ADVANCE-ID.
🔗 bit.ly/4rmSteA
@advance-id.bsky.social
Join a global, online and open-access conference our antimicrobial chemotherapy, AMR and the future of antibiotic innovation.
🗓️ 4–5 Feb 2026 | 🌍 Online
🔗 Last chance to register: https://eventsair.pulse.ly/35puv6u0m6
#ACC2026
Join a global, online and open-access conference our antimicrobial chemotherapy, AMR and the future of antibiotic innovation.
🗓️ 4–5 Feb 2026 | 🌍 Online
🔗 Last chance to register: https://eventsair.pulse.ly/35puv6u0m6
#ACC2026
🔗 Register: bit.ly/4t29ooI
🔗 Register: bit.ly/4t29ooI
You can also explore and meet key organizations in #antimicrobialR&D!
⏩Full list in next post
📅4&5 Feb
✍️Register: acc-conference.com
You can also explore and meet key organizations in #antimicrobialR&D!
⏩Full list in next post
📅4&5 Feb
✍️Register: acc-conference.com
You. Are. Missing. Out!
The speaker line-up is just top-notch! I mean, just look at this: acc-conference.com 🤩
#AMR #antimicrobialR&D #openaccess #ACC2026
You. Are. Missing. Out!
The speaker line-up is just top-notch! I mean, just look at this: acc-conference.com 🤩
#AMR #antimicrobialR&D #openaccess #ACC2026
I was very unlucky to almost "manage" to die from PPH in a rich country like Switzerland, but I was SO lucky to have access to all care, tools, knowledge and medicines needed to keep me alive.
A new commentary reflects on progress since the launch of the PPH Roadmap, and why urgent, coordinated action is needed to end preventable deaths from PPH—still a leading cause of maternal mortality.
🔗 bit.ly/3IMs0qm
I was very unlucky to almost "manage" to die from PPH in a rich country like Switzerland, but I was SO lucky to have access to all care, tools, knowledge and medicines needed to keep me alive.
As I am nearing the 4th anniversary of almost dying from #postpartumhaemorrhage, I am thrilled to see that blood donation criteria in Switzerland will change from 1 Feb, allowing more people to become donors. I hope to be one of them soon!
shorturl.at/KstxJ
As I am nearing the 4th anniversary of almost dying from #postpartumhaemorrhage, I am thrilled to see that blood donation criteria in Switzerland will change from 1 Feb, allowing more people to become donors. I hope to be one of them soon!
shorturl.at/KstxJ
This free, global, online conference brings together leading minds and experts to explore what’s next for antimicrobial chemotherapy.
Co-organized by GARDP and BSAC
📅 4–5 Feb 2026 |🌍 Online
🔗 Register now: bit.ly/4pSEdt7
@bsacandjac.bsky.social @advance-id.bsky.social
This free, global, online conference brings together leading minds and experts to explore what’s next for antimicrobial chemotherapy.
Co-organized by GARDP and BSAC
📅 4–5 Feb 2026 |🌍 Online
🔗 Register now: bit.ly/4pSEdt7
@bsacandjac.bsky.social @advance-id.bsky.social
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
💊 GARDP’s upgraded open-access database is a go-to tool for researchers, developers & innovators in the antibiotic space.
Start exploring🔗 revive.gardp.org/antibioticdb/
#REVIVE
💊 GARDP’s upgraded open-access database is a go-to tool for researchers, developers & innovators in the antibiotic space.
Start exploring🔗 revive.gardp.org/antibioticdb/
#REVIVE